AristaMD Appoints Julia Jezmir, MD, MBA, as President and Chief Medical Officer

Expanded leadership role accelerates AristaMD’s vision to be the specialty care “easy button” for risk-bearing primary care provider organizations.

SAN DIEGO, Calif., June 4, 2026 — AristaMD, the premier virtual-first specialty medical corporation, which empowers risk-bearing primary care organizations to consistently, sustainably and profitably deliver high-quality patient care, today announced the promotion of Chief Medical Officer Julia Jezmir, MD, MBA, to President.

Building on the company’s decade of experience as the leading provider of e-consult solutions, Dr. Jezmir, in her dual role, will lead AristaMD’s next phase of growth, expanding specialty care capabilities and clinical strategies to improve patient outcomes and reduce the total cost of care.

“Julia has been the driving force behind our clinical and business innovation, architecting our clinical and operational strategy and collaborating with industry-leading PCP clients to develop high-impact, patient-centric, provider-focused specialty-care solutions.  Equally important, she has developed an incredible service delivery ecosystem and culture which yields a top-quadrant net promoter score from both clients and employees,” said Keith Pinter, CEO of AristaMD. “Her passion for truly helping our PCP clients along with her proven clinical and business leadership will take us to the next level of serving as the ‘easy button’ for specialty care – essential as value-based care continues to accelerate”

The appointment underscores AristaMD’s commitment to clinically driven services that enhance access to specialty care, coordination, and affordability.

“Julia’s appointment as President reflects the Board’s confidence in both her leadership and AristaMD’s strategic direction,” said John Kuelper, chairman of the board of AristaMD. “Her ability to connect clinical excellence with operational discipline has helped position AristaMD for its next stage of growth and innovation. As the healthcare landscape continues to evolve, Julia’s leadership will help ensure the company remains focused on delivering meaningful value for the organizations and patients it serves.”